Registry of Lobbyists

Advanced Registry Search Results

Registration (68)
Results: 1-50 | Export
  1. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Clarissa Schurter, Edelman Global Advisory
    Registration: 1 of 1 (2024-02-15 to present)
    Posted: 2024-02-27
    Subject matter details: 7
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  2. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Alexander MacDonald, Counsel Public Affairs Inc.
    Registration: 1 of 1 (2024-01-29 to present)
    Posted: 2024-02-07
    Subject matter details: 12
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  3. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 19 of 19 (2023-10-09 to present)
    Posted: 2023-10-10
    Subject matter details: 12
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  4. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 6 of 6 (2023-09-25 to present)
    Posted: 2023-09-29
    Subject matter details: 7
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  5. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 5 of 6 (2023-09-20 to 2023-09-25)
    Posted: 2023-09-20
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  6. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 4 of 6 (2023-06-09 to 2023-09-20)
    Posted: 2023-06-09
    Subject matter details: 4
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  7. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 2 of 2 (2023-04-06 to 2023-05-08)
    Posted: 2023-04-11
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  8. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 1 of 2 (2023-03-29 to 2023-04-06)
    Posted: 2023-03-30
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  9. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 3 of 6 (2023-03-09 to 2023-06-09)
    Posted: 2023-03-10
    Subject matter details: 3
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  10. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: John Delacourt, Counsel Public Affairs
    Registration: 2 of 2 (2023-01-31 to present)
    Posted: 2023-03-15
    Subject matter details: 15
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  11. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: John Delacourt, Counsel Public Affairs
    Registration: 1 of 2 (2022-11-25 to 2023-01-31)
    Posted: 2022-12-05
    Subject matter details: 15
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  12. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Registration: 2 of 6 (2022-10-26 to 2023-03-09)
    Posted: 2022-10-26
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  13. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Affairs / Ashley M Brambles
    Registration: 1 of 6 (2022-10-24 to 2022-10-26)
    Posted: 2022-10-25
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  14. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Pierre Cyr, Edelman Global Advisory
    Registration: 1 of 1 (2022-10-24 to 2024-03-13)
    Posted: 2022-10-28
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  15. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 18 of 19 (2022-06-14 to 2023-10-09)
    Posted: 2022-06-15
    Subject matter details: 15
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  16. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Marsha Seca, Edelman Canada / Edelman
    Registration: 1 of 1 (2022-05-10 to 2022-11-16)
    Posted: 2022-06-10
    Subject matter details: 3
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  17. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 12 of 12 (2022-01-18 to 2022-04-22)
    Posted: 2022-01-20
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  18. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: David Murray, Counsel Public Affairs Inc.
    Registration: 4 of 4 (2022-01-18 to 2022-09-23)
    Posted: 2022-01-20
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  19. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 11 of 11 (2022-01-18 to 2022-11-28)
    Posted: 2022-01-20
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  20. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 17 of 19 (2022-01-18 to 2022-06-14)
    Posted: 2022-01-20
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  21. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 11 of 12 (2021-12-01 to 2022-01-18)
    Posted: 2021-12-06
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  22. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 10 of 11 (2021-12-01 to 2022-01-18)
    Posted: 2021-12-06
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  23. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: David Murray, Counsel Public Affairs Inc.
    Registration: 3 of 4 (2021-12-01 to 2022-01-18)
    Posted: 2022-01-14
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  24. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 16 of 19 (2021-12-01 to 2022-01-18)
    Posted: 2022-01-14
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  25. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 10 of 12 (2021-09-22 to 2021-12-01)
    Posted: 2021-09-22
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  26. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 9 of 12 (2021-06-02 to 2021-08-11)
    Posted: 2021-07-15
    Subject matter details: 14
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  27. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: David Murray, Counsel Public Affairs Inc.
    Registration: 2 of 4 (2021-03-10 to 2021-12-01)
    Posted: 2021-03-15
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  28. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: David Murray, Counsel Public Affairs Inc.
    Registration: 1 of 4 (2021-03-01 to 2021-03-10)
    Posted: 2021-03-04
    Subject matter details: 14
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  29. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 9 of 11 (2021-02-24 to 2021-12-01)
    Posted: 2021-03-15
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  30. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 8 of 12 (2021-02-24 to 2021-06-02)
    Posted: 2021-03-15
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  31. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 15 of 19 (2021-02-24 to 2021-12-01)
    Posted: 2021-03-15
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  32. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 14 of 19 (2021-02-01 to 2021-02-24)
    Posted: 2021-02-03
    Subject matter details: 14
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  33. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 8 of 11 (2021-02-01 to 2021-02-24)
    Posted: 2021-02-03
    Subject matter details: 14
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  34. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 7 of 12 (2021-02-01 to 2021-02-24)
    Posted: 2021-02-03
    Subject matter details: 14
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  35. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Amber Ruddy, Counsel Public Affairs Inc.
    Registration: 4 of 4 (2021-02-01 to 2021-02-03)
    Posted: 2021-02-03
    Subject matter details: 14
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  36. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 6 of 12 (2020-12-03 to 2021-02-01)
    Posted: 2020-12-23
    Subject matter details: 13
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  37. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 13 of 19 (2020-12-03 to 2021-02-01)
    Posted: 2020-12-23
    Subject matter details: 13
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  38. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 7 of 11 (2020-12-03 to 2021-02-01)
    Posted: 2020-12-23
    Subject matter details: 13
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  39. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Amber Ruddy, Counsel Public Affairs Inc.
    Registration: 3 of 4 (2020-12-03 to 2021-02-01)
    Posted: 2020-12-23
    Subject matter details: 13
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  40. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 5 of 12 (2020-10-08 to 2020-12-03)
    Posted: 2020-10-09
    Subject matter details: 12
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  41. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 6 of 11 (2020-10-08 to 2020-12-03)
    Posted: 2020-10-09
    Subject matter details: 12
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  42. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Amber Ruddy, Counsel Public Affairs Inc.
    Registration: 2 of 4 (2020-10-08 to 2020-12-03)
    Posted: 2020-10-09
    Subject matter details: 12
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  43. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 12 of 19 (2020-10-08 to 2020-12-03)
    Posted: 2020-10-09
    Subject matter details: 12
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  44. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 11 of 19 (2020-09-29 to 2020-10-08)
    Posted: 2020-09-30
    Subject matter details: 10
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  45. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Amber Ruddy, Counsel Public Affairs Inc.
    Registration: 1 of 4 (2020-09-28 to 2020-10-08)
    Posted: 2020-09-29
    Subject matter details: 10
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  46. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 4 of 12 (2020-09-24 to 2020-10-08)
    Posted: 2020-09-25
    Subject matter details: 10
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  47. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 10 of 19 (2020-09-24 to 2020-09-29)
    Posted: 2020-09-25
    Subject matter details: 10
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  48. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ben Parsons, Counsel Public Affairs Inc.
    Registration: 5 of 11 (2020-09-24 to 2020-10-08)
    Posted: 2020-09-25
    Subject matter details: 10
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  49. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Sheamus Murphy, Counsel Public Affairs Inc.
    Registration: 9 of 19 (2020-06-29 to 2020-09-24)
    Posted: 2020-06-30
    Subject matter details: 10
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  50. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Bridget Howe, Counsel Public Affairs Inc.
    Registration: 3 of 12 (2020-06-01 to 2020-09-24)
    Posted: 2020-06-03
    Subject matter details: 10
    Government institutions: 9
    Communication techniques: 3
    Government funding: No

Date Modified: